Memorial Sloan Kettering Cancer Center Update on the Multimodality Management of Bladder and Kidney Cancer 2024

Memorial Sloan Kettering Cancer Center Update on the Multimodality Management of Bladder and Kidney Cancer 2024

$40.00

+ Include: 45 videos + 37 pdfs, size: 6.04 GB

+ Target Audience: urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists

Description

+ Include: 45 videos + 37 pdfs, size: 6.04 GB

+ Target Audience: urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists

+ Sample video: contact me for sample video

+ Information:

Date & Location Thursday, November 21, 2024, 12:00 PM – Saturday, November 23, 2024, 1:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties – Anatomic Pathology, Biostatistics, Clinical Pathology, Cytopathology, Epidemiology, General Surgery, Genetic Counseling, Genitourinary Oncology, Hospitalist, Immunotherapy, Industry, Internal Medicine, Molecular Biology, Molecular Pathology, Nuclear Medicine, Nursing, Oncology and Hematology, Pathology, Patient or Caregiver, Physician Assistant, Radiation Oncology, Surgical Oncology, Surgical Pathology, Urology
Overview

This program is designed to highlight the latest developments in the multidisciplinary management of bladder and kidney cancers. The aim of the course is provide attendees with information that will aid in the delivery of state-of-the-art care to patients with all stages of bladder and kidney cancers. Highlights of this year’s program include:

— Management strategies for localized kidney cancer and non-muscle invasive bladder cancer

— Neoadjuvant and adjuvant systemic therapies for muscle-invasive bladder cancer

— Treatment paradigms for advanced kidney cancer and optimal surgical approaches for high-risk cases

— Advanced imaging modalities for kidney cancer

— The role of intraoperative and SBRT techniques for treating bladder and kidney cancers

— A review of hereditary kidney cancer syndromes

The keynote presentation will detail the new standards in managing advanced urothelial cancer. Updated trial data will be presented, detailing recent changes in the standard of care for advanced urothelial cancer, focusing on combination therapies that include novel antibody-drug conjugates and checkpoint inhibitors. Additionally, the program will include video sessions that highlight surgical techniques for urinary diversion, utilizing both open and robotic methods, as well as radical nephrectomy with thrombectomy.

This course is intended for urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses, and other healthcare professionals.

Objectives
At the conclusion of this program, attendees will be able to:
  1. Present a multidisciplinary approach to the management of bladder and kidney cancer including surgical, medical, and radiation therapies
  2. Disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer
  3. Integrate new therapeutics into the treatment of localized, locally advanced, and metastatic bladder and kidney cancers

 

+ Topics:

Ablation Strategies for Small Renal Masses.mp4

Ablation Strategies for Small Renal Masses.pdf

Atypical Recurrences Following Minimal Invasive Kidney Surgeries.mp4

Atypical Recurrences Following Minimal Invasive Kidney Surgeries.pdf

Bladder Preservation Options for Muscle Invasive Bladder Cancer- I. Systemic Therapy Alone.mp4

Bladder Preservation Options for Muscle Invasive Bladder Cancer- I. Systemic Therapy Alone.pdf

Bladder Preservation Options for Muscle Invasive Bladder Cancer- II. Partial Cystectomy.mp4

Bladder Preservation Options for Muscle Invasive Bladder Cancer- II. Partial Cystectomy.pdf

Bladder Preservation Options for Muscle Invasive Bladder Cancer- III. Trimodality Therapy.mp4

Bladder Preservation Options for Muscle Invasive Bladder Cancer- III. Trimodality Therapy.pdf

BladderKidney2024_Brochure.pdf

Contemporary Nuclear Medicine Diagnostics in Renal Cell Carcinoma.mp4

Contemporary Nuclear Medicine Diagnostics in Renal Cell Carcinoma.pdf

Contemporary QOL After Radical Cystectomy and Urinary Diversion- MSK Prospective Trial Data.mp4

Contemporary QOL After Radical Cystectomy and Urinary Diversion- MSK Prospective Trial Data.pdf

Contemporary Standards in the Treatment of Refractory Renal Cell Carcinoma.mp4

Contemporary Standards in the Treatment of Refractory Renal Cell Carcinoma.pdf

Current Paradigms in the Management of Newly Diagnosed Metastatic Renal Cell Carcinoma.mp4

Current Paradigms in the Management of Newly Diagnosed Metastatic Renal Cell Carcinoma.pdf

Current Status of BCG Shortage- Management Alternatives and Strategies for NMIBC.mp4

Current Status of BCG Shortage- Management Alternatives and Strategies for NMIBC.pdf

Current Surgical Paradigms in the Management of Small Renal Masses.mp4

Current Surgical Paradigms in the Management of Small Renal Masses.pdf

Emerging Role of Urinary Markers for NMIBC Detection.mp4

Emerging Role of Urinary Markers for NMIBC Detection.pdf

Enhancing Outpatient Support to Improve Outcomes in Bladder Cancer.mp4

Enhancing Outpatient Support to Improve Outcomes in Bladder Cancer.pdf

Evolving Role of Cytoreductive Nephrectomy and Metastasectomy in the Era of Checkpoint Inhibitor Therapy.mp4

Evolving Role of Cytoreductive Nephrectomy and Metastasectomy in the Era of Checkpoint Inhibitor Therapy.pdf

Hereditary GU Syndromes and RCC Panel Discussion Q&A.mp4

Hereditary Syndromes with Predisposition to Bladder and Kidney Cancers.mp4

Hereditary Syndromes with Predisposition to Bladder and Kidney Cancers.pdf

Impact of Variant Histology on Urothelial Cancer Treatment.mp4

Impact of Variant Histology on Urothelial Cancer Treatment.pdf

Later Line Therapies.mp4

Later Line Therapies.pdf

Localized and Metastatic Bladder Cancer Panel Discussion Q&A.mp4

Localized Bladder Cancer (I & II) Panel Discussion Q&A and Case Presentations.mp4

Localized Kidney Cancer (I & II) Panel Discussion Q&A and Case Presentations.mp4

Locally Advanced Kidney Cancer Panel Discussion Q&A and Case Presentations.mp4

Management of Brain and Spinal Cord Metastases Using Contemporary Radiation Strategies.mp4

Management of Brain and Spinal Cord Metastases Using Contemporary Radiation Strategies.pdf

Management of IVC Thrombi in the Era of Immunotherapy.mp4

Management of IVC Thrombi in the Era of Immunotherapy.pdf

Management of Skin Toxicities of Antibody Drug Conjugates and Immune Checkpoint Inhibitors.mp4

Management of Skin Toxicities of Antibody Drug Conjugates and Immune Checkpoint Inhibitors.pdf

Metastatic Kidney Cancer (I) Panel Discussion Q&A and Case Presentations.mp4

Metastatic Kidney Cancer (II) Panel Discussion Q&A and Case Presentations.mp4

Modern ERAS Protocols for Radical Cystectomy.mp4

Modern ERAS Protocols for Radical Cystectomy.pdf

Molecular Imaging for Bladder Cancer- Now and Future.mp4

Molecular Imaging for Bladder Cancer- Now and Future.pdf

New Approaches for High Risk Localized Upper Tract Urothelial Cancer.mp4

New Approaches for High Risk Localized Upper Tract Urothelial Cancer.pdf

New Standards in the Management of Advanced Urothelial Cancer.mp4

New Standards in the Management of Advanced Urothelial Cancer.pdf

Non-Muscle Invasive Bladder Cancer Panel Discussion Q&A and Case Presentations.mp4

Novel Approaches in the Systemic Treatment of Advanced Renal Cell Carcinoma.mp4

Novel Approaches in the Systemic Treatment of Advanced Renal Cell Carcinoma.pdf

Pivotal Data for Adjuvant Immunotherapy in Resected Renal Cell Carcinoma.mp4

Pivotal Data for Adjuvant Immunotherapy in Resected Renal Cell Carcinoma.pdf

Review of Randomized Trial Data for the Role of Pelvic Lymph Node Dissection in Muscle Invasive Bladder Cancer.mp4

Review of Randomized Trial Data for the Role of Pelvic Lymph Node Dissection in Muscle Invasive Bladder Cancer.pdf

Role for Surgery in Advanced Disease.mp4

Role for Surgery in Advanced Disease.pdf

Role for White Light Enhanced Technologies for Bladder Cancer Detection and Treatment.mp4

Role for White Light Enhanced Technologies for Bladder Cancer Detection and Treatment.pdf

SBRT as a Strategy to Treat Renal Masses in the Non-Metastatic Setting.mp4

SBRT as a Strategy to Treat Renal Masses in the Non-Metastatic Setting.pdf

SBRT to non-CNS sites in the Management of Advanced Kidney Cancer.mp4

SBRT to non-CNS sites in the Management of Advanced Kidney Cancer.pdf

Surveillance Strategies for Small Renal Masses.mp4

Surveillance Strategies for Small Renal Masses.pdf

Systemic Treatment for Uncommon Kidney Cancer Variants.mp4

Systemic Treatment for Uncommon Kidney Cancer Variants.pdf

The Role of Adjuvant Therapy for High-Risk Muscle Invasive Bladder Cancer.mp4

The Role of Adjuvant Therapy for High-Risk Muscle Invasive Bladder Cancer.pdf

Update on Treatment Options for BCG Unresponsive NMIBC.mp4

Update on Treatment Options for BCG Unresponsive NMIBC.pdf

Updates in Neoadjuvant Therapy for Muscle Invasive Bladder Cancer.mp4

Updates in Neoadjuvant Therapy for Muscle Invasive Bladder Cancer.pdf

VIDEO SESSION- Tips and Tricks for Continent Urinary Diversion.mp4

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center Update on the Multimodality Management of Bladder and Kidney Cancer 2024”

Your email address will not be published. Required fields are marked *

Related Products